Zanotti KM - Search Results

1

Gynecologic cancer care in the first year of the COVID-19 pandemic.

Chapman GC, Smrz SA, Gordon JC, Lynam SK, Strohl AE, Ferguson LA, Armstrong AJ, Zanotti KM. Chapman GC, et al. Among authors: zanotti km. Gynecol Oncol. 2023 Nov;178:138-144. doi: 10.1016/j.ygyno.2023.09.007. Epub 2023 Oct 19. Gynecol Oncol. 2023. PMID: 37862793

2

Diagnosis and management of endometrial hyperplasia.

Armstrong AJ, Hurd WW, Elguero S, Barker NM, Zanotti KM. Armstrong AJ, et al. Among authors: zanotti km. J Minim Invasive Gynecol. 2012 Sep-Oct;19(5):562-71. doi: 10.1016/j.jmig.2012.05.009. Epub 2012 Aug 3. J Minim Invasive Gynecol. 2012. PMID: 22863972 Review.

3

Enhanced gastric decompression for palliation of malignant bowel obstruction.

Cole JM, Khan SZ, Marks JM, Armstrong AJ, Zanotti KM, Juza RM. Cole JM, et al. Among authors: zanotti km. Surg Endosc. 2023 May;37(5):4000-4004. doi: 10.1007/s00464-022-09554-7. Epub 2022 Sep 7. Surg Endosc. 2023. PMID: 36071261

4

Standardization of Laparoscopic Operative Reporting: Improving Gynaecological Surgeon Communication.

Pope RJ, Abdelbadee AY, Armstrong AJ, Ganesh PR, Bedaiwy MA, Zanotti KM. Pope RJ, et al. Among authors: zanotti km. J Obstet Gynaecol Can. 2018 Mar;40(3):304-309. doi: 10.1016/j.jogc.2017.07.023. Epub 2017 Oct 12. J Obstet Gynaecol Can. 2018. PMID: 29032066

5

Skin toxicity associated with pegylated liposomal doxorubicin (40 mg/m2) in the treatment of gynecologic cancers.

Kim RJ, Peterson G, Kulp B, Zanotti KM, Markman M. Kim RJ, et al. Among authors: zanotti km. Gynecol Oncol. 2005 May;97(2):374-8. doi: 10.1016/j.ygyno.2004.12.057. Gynecol Oncol. 2005. PMID: 15863132

6

Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.

Nagaraj AB, Joseph P, Kovalenko O, Singh S, Armstrong A, Redline R, Resnick K, Zanotti K, Waggoner S, DiFeo A. Nagaraj AB, et al. Oncotarget. 2015 Sep 15;6(27):23720-34. doi: 10.18632/oncotarget.4690. Oncotarget. 2015. PMID: 26125441 Free PMC article.

7

The oncology care model and the future of alternative payment models: A gynecologic oncology perspective.

Aviki EM, Schleicher SM, Boyd L, Liang M, Ko EM, Zanotti K, Moss H. Aviki EM, et al. Gynecol Oncol. 2021 Sep;162(3):529-531. doi: 10.1016/j.ygyno.2021.07.014. Epub 2021 Jul 20. Gynecol Oncol. 2021. PMID: 34294415 No abstract available.

8

Experience with the management of neutropenia in gynecologic cancer patients receiving carboplatin-based chemotherapy.

Markman J, Zanotti K, Webster K, Belinson J, Peterson G, Kulp B, Markman M. Markman J, et al. Gynecol Oncol. 2004 Feb;92(2):592-5. doi: 10.1016/j.ygyno.2003.11.005. Gynecol Oncol. 2004. PMID: 14766252

9

Small-Molecule-Mediated Stabilization of PP2A Modulates the Homologous Recombination Pathway and Potentiates DNA Damage-Induced Cell Death.

Avelar RA, Armstrong AJ, Carvette G, Gupta R, Puleo N, Colina JA, Joseph P, Sobeck AM, O'Connor CM, Raines B, Gandhi A, Dziubinski ML, Ma DS, Resnick K, Singh S, Zanotti K, Nagel C, Waggoner S, Thomas DG, Skala SL, Zhang J, Narla G, DiFeo A. Avelar RA, et al. Mol Cancer Ther. 2023 May 4;22(5):599-615. doi: 10.1158/1535-7163.MCT-21-0880. Mol Cancer Ther. 2023. PMID: 36788429 Free PMC article.

10

Cardiac safety profile of prolonged (>or=6 cycles) pegylated liposomal doxorubicin administration in patients with gynecologic malignancies.

Uyar D, Kulp B, Peterson G, Zanotti K, Markman M, Belinson J. Uyar D, et al. Gynecol Oncol. 2004 Jul;94(1):147-51. doi: 10.1016/j.ygyno.2004.03.024. Gynecol Oncol. 2004. PMID: 15262133

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters